News

AddToAny

Google+ Facebook Twitter Twitter

3D model of human liver

Non-alcoholic fatty liver disease is becoming the most common chronic liver disorder in developed countries.

Histological analysis of liver tissue is the only widely accepted test for diagnosing and distinguishing different stages of the disease.

However, this technique provides only two-dimensional images of the liver tissue in low resolution and overlooks potentially important 3D structural changes.

Scientists have now generated 3D geometrical and functional models of human liver tissue for different disease stages. They reveal new critical tissue alterations, providing new insights into pathophysiology and contributing to high-definition medical diagnosis.

Conventional histological analysis of liver tissue is the gold standard for diagnosing disease progression, but it has several potential disadvantages: the low-resolution 2D images of liver tissue may only allow a semi-quantitative evaluation and it can be subjective, since it depends on interpretation.  

go.nature.com/2t42Dco

Image credit | Shutterstock

Related Articles

illustration_CREDIT_istock-484714523

Advanced and consultant practice roles

Sarah May and Chris Ward from the IBMS look at advanced and consultant roles and discuss new developments and qualifications.

Robotic hand with handgun aiming in wrong direction. Fatal AI error - Image credit - Shutterstock-2309476357

Tissue contamination distracts AI

In a new study, scientists trained three AI models to scan microscope slides of placenta tissue to detect blood vessel damage, estimate gestational age and classify macroscopic lesions.

Digital pathology cleared for use-history digital pathology-CREDIT-university of warwick

Digital pathology cleared for use

New research has led to the UK government approving the use of digital pathology to help speed up analysis of cancer screening samples.

Breast cancer 3D tomography-CREDIT-Science-Photo-Library-c0303374

Two decades of hHER2 testing

This year marks the 20th anniversary of Her2 breast cancer testing at the Royal Cornwall Hospital. Senior Biomedical Scientist Mary Jones looks back over the past two decades.

Top